Management of Ovarian Carcinoma

Abstract

Despite many dramatic and rapid advances in the treatment of cancer during the last 20 years, the management of ovarian cancer remains unsatisfactory. Although surgical and radiotherapeutic technics have improved, the survival figures for ovarian cancer have not. The five-year survival rate has improved only from 29 per cent (1950–1959) to 32 per cent (1965–1969).¹ At present, approximately 11,000 deaths occur from this disease in the United States each year, with a further 3000 deaths per annum in the United Kingdom.^{2 , 3} This figure represents a death rate greater than that for neoplasms of the cervix and corpus uteri combined. Since . . .